<p>TORONTO, Canada — The United States Food and Drug Administration has issued a warning letter to a company that appears to sell products containing human fecal matter without approval from the a
</p><p>This type of therapy should only be used in the context of an authorized clinical trial, or to treat patients with recurrent Clostridium difficile, also known as C.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: